AutoGenomics, which provides a molecular diagnostics system for genetic testing in clinical laboratories, refiled on Tuesday with the SEC to raise up to $60 million in an initial public offering.
The company last tried to go public in February 2013, when it set terms to raise $60 million at a $188 million market value, before postponing and eventually withdrawing last November. AutoGenomics first filed for an $86 million IPO in 2008, but withdrew its submission in 2011.
Help employers find you! Check out all the jobs and post your resume.
